EFFECT OF THE NON-PEPTIDE THROMBOPOIETIN RECEPTOR AGONIST ELTROMBOPAG (PROMACTA (R)/REVOLADETM) ON BONE MARROW CELLS FROM PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL（2009）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined